Impact of T. vaginalis infection on innate immune responses and reproductive outcome
Section snippets
Unique features of T. vaginalis: more than 170 years of history
Trichomonas vaginalis is a sexually transmitted extracellular flagellated single-cell parasite that lives in the female lower reproductive tract and the male urethra. Unique genetic and structural features place the parasite at the base of the eukaryotic phylogenetic tree and suggest an intriguing evolution toward mucosal parasitism. T. vaginalis selectively adheres to the human vaginal epithelial cells, surviving for years in the hostile vaginal environment that is typically acidic, contains a
Clinical manifestations and impact on reproductive health
In women T. vaginalis causes a wide spectrum of symptoms, ranging from a relatively asymptomatic state to severe inflammation and irritation with foul-smelling vaginal discharge, low abdominal pain, and dysuria. The associated morbidities and complications include vaginitis, endometritis, adnexitis, pyosalpinx, atypical pelvic inflammatory disease, preterm birth, premature membrane rupture, low birth weight, infertility, cervical cancer, enhanced risk of HIV-1 and other viral infections, and a
Alarming epidemiologic trends
Worldwide 160–180 million people are infected with T. vaginalis each year, and of those 154 million are in resource-limited settings; 8–10 million are in the United States and 11 million are in Europe (McClelland, 2008). The incidence of T. vaginalis infection occurs more than Chlamydia and gonorrhea put together. In the United States the prevalence among women ranges from 2.8% in adolescents nationwide to 51% in some black communities (Shafir et al., 2009). In men statistics is less reliable
Immunoinflammatory responses to T. vaginalis infection in pregnant women
The immunoinflammatory response to trichomoniasis has been most studied in pregnant women. T. vaginalis positive pregnant women with bacterial vaginosis (Nugent 7-10) had increased vaginal IL-1β and neutrophils compared with bacterial vaginosis alone (Cauci and Culhane, 2007). Increased cervical IL-8 and alpha-defensin have been found in pregnant infected women (Simhan et al., 2007). At the same time in symptomatic women, anti-inflammatory mediators such as the soluble leukocyte protease
Modeling the infection and immunity in vivo and in vitro
The immunoinflammatory responses to T. vaginalis infection have been studied in vitro and in mouse models. In vitro experimentation has been conducted with cervical and vaginal epithelial cells (Bastida-Corcuera et al., 2005, Fichorova et al., 2006, Kucknoor et al., 2005a, Kucknoor et al., 2005b, Kucknoor et al., 2007, Okumura et al., 2008, Singh et al., 2009, Sommer et al., 2005), and with various immune cell types (Chang et al., 2006a, Chang et al., 2004, Ryu et al., 2004, Shaio et al., 1995
The T. vaginalis lipophosphoglycan—functional domains and innate immunity mechanisms
The T. vaginalis lipophosphoglycan (LPG) has become the focus of extensive studies ever since it was discovered that it is the most abundant glycoconjugate on the parasite surface (2–3 × 106 copies/parasite) and is responsible for the parasite adherence to the vaginal epithelial cells (Singh et al., 2007). It is a pure carbolipid (no peptide component) anchored on the parasite surface via inositol-phosphoceramide. Unlike LPG from other parasites (Leishmania), Trichomonas LPG does not undergo
Future directions
Future studies are needed to identify the host receptors and the host's as well as parasite's pathways involved in the symptomatic and asymptomatic sequelae and immune evasion by T. vaginalis. The mechanisms of the synergistic interactions between T. vaginalis and bacterial vaginosis, the most common vaginal syndrome of reproductive age women, are virtually unknown. More research is needed to understand and prevent the negative impact of T. vaginalis on women's reproductive health and the risk
Acknowledgments
The work on T. vaginalis immunobiology in the author's laboratory has been supported by NIH/NICHD grants R21HD054451-01 and R21HD054451-02 with continued support by NIH/NIAID R01AI079085-01A2. The author would like to acknowledge the collaboration of her laboratory with the laboratories of Dr. B.N. Singh (SUNY Upstate Medical University, NY, USA), and Dr. C. Costello (Boston University School of Medicine, MA, USA), which have played a significant role in elucidating the molecular structure and
References (49)
- et al.
Apoptosis of macrophages induced by Trichomonas vaginalis through the phosphorylation of p38 mitogen-activated protein kinase that locates at downstream of mitochondria-dependent caspase activation
Int. J. Biochem. Cell Biol.
(2006) - et al.
Trichomonas vaginalis inhibits proinflammatory cytokine production in macrophages by suppressing NF-kappaB activation
Mol. Cells
(2004) - et al.
Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption
Virology
(2008) - et al.
Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells
J. Biol. Chem.
(2005) - et al.
Molecular biology of the amitochondriate parasites, Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis
Int. J. Parasitol.
(2003) - et al.
Trichomonas vaginalis infection activates cells through toll-like receptor 4
Clin. Immunol.
(2004) - et al.
Comparative analysis of trichomonad genome sizes and karyotypes
Mol. Biochem. Parasitol.
(2008) - et al.
Comparison between secretory leukocytic protease inhibitor and reactive nitrogen intermediates levels in cervicovaginal secretions from symptomatic and asymptomatic trichomoniasis Egyptians patients
J. Egypt Soc. Parasitol.
(2006) - et al.
Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants
Infect. Immun.
(1986) - et al.
Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells
Eukaryot. Cell
(2005)
Trichomonas adhere and phagocytose sperm cells: adhesion seems to be a prominent stage during interaction
Parasitol. Res.
Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs
Infect. Dis. Obstet. Gynecol.
Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis
Science
Modulation of vaginal immune response among pregnant women with bacterial vaginosis by Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and yeast
Am. J. Obstet. Gynecol.
Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells
Immunology
Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor
J. Infect. Dis.
Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins
Biol. Reprod.
Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells
Infect. Immun.
T. vaginalis LPG regulates cytokine responses via binding galectins on human vaginal epithelial cells
Microbicides
The tat protein of HIV-1 induces galectin-3 expression
Glycobiology
A proteome reference map of Trichomonas vaginalis
Parasitol. Res.
Sentinel surveillance of sexually transmitted infections in South Africa: a review
Sex Transm. Infect.
Trichomonas vaginalis promotes apoptosis of human neutrophils by activating caspase-3 and reducing Mcl-1 expression
Parasite Immunol.
Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis
Parasitol. Res.
Cited by (165)
Unconventional features in the transcription and processing of spliceosomal small nuclear RNAs in the protozoan parasite Trichomonas vaginalis
2024, International Journal for ParasitologyTrichomoniasis
2023, Infectious Disease Clinics of North AmericaTrichomoniasis, a new look at a common but neglected STI in African descendance population in the United States and the Black Diaspora. A review of its incidence, research prioritization, and the resulting health disparities
2022, Journal of the National Medical AssociationCitation Excerpt :Studies on the immunoinflammatory responses to trichomoniasis have mostly been in pregnant women. Studies show that pregnant women with trichomoniasis have increased IL-1β and neutrophils in their vaginal secretions.77 Also, an increase in IL-8 is found in the cervix of infected pregnant women.
First identification of telomeric DNA sequences in Trichomonas vaginalis
2022, Acta Tropica